Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapeutic perspectives in heart failure]].

Jochen Müller-Ehmsen1, Robert H Schwinger

  • 1Klinik III für Innere Medizin der Universität zu Köln. muller.ehmsen@uni-koeln.de

Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung
|June 17, 2003
PubMed
Summary

New heart failure treatments are crucial due to poor patient outcomes. Investigating novel therapies like mechanical devices, gene therapy, and cellular cardiomyoplasty offers hope for improving heart function and survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2023
Same author

[Acute Aortic Dissection: A Life-Threatening Disease Also in Neurological Emergency Medicine].

Fortschritte der Neurologie-Psychiatrie·2022
Same author

Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy.

Clinical research in cardiology : official journal of the German Cardiac Society·2019
Same author

Prediction of survival on the waiting list for heart transplantation and of posttransplant nonadherence-Results of a prospective longitudinal study.

Clinical transplantation·2019
Same author

An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany.

BMC cardiovascular disorders·2018
Same author

Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.

International journal of cardiology·2018

Area of Science:

  • Cardiology and Regenerative Medicine
  • Biomedical Engineering

Context:

  • Heart failure, despite uniform symptoms and treatment principles, significantly impacts patient quality of life and survival.
  • Limited donor organ availability restricts cardiac transplantation, necessitating innovative therapeutic strategies.
  • Current medical therapies aim to counteract decreased contractility and neurohumoral activation in heart failure.

Purpose:

  • To explore novel therapeutic strategies and technologies for effectively treating heart failure.
  • To review emerging treatments including pharmacological agents, mechanical/electrical devices, gene therapy, and cellular cardiomyoplasty.
  • To highlight the need for advancements beyond current medical management for heart failure patients.

Summary:

  • Investigational therapies include neutral endopeptidase inhibitors, endothelin antagonists, and TNF antagonists.

Related Experiment Videos

  • Mechanical and electrical devices like left ventricular assist devices (LVADs) and biventricular pacemakers are under development.
  • Gene therapy and cellular cardiomyoplasty offer potential for myocardial repair and regeneration, though long-term efficacy requires further study.
  • Impact:

    • Novel strategies aim to break the cycle of decreased contractility and neurohumoral activation in heart failure.
    • Mechanical devices, gene therapy, and cellular cardiomyoplasty represent promising alternative or adjunctive therapies.
    • Successful implementation of these advanced treatments could significantly improve heart failure management and patient outcomes.